Biovest product gets orphan drug status from FDA - Bizjournals.com
Biovest product gets orphan drug status from FDABizjournals.comThe US Food and Drug Administration has granted orphan drug designation to BiovaxID for the treatment of mantle cell lymphoma, putting the company one step ...FDA Grants Orphan Drug Status for Personalized Cancer Vaccine, BiovaxID(R ...MarketWatch (press release)Biovest's cancer vaccine receives FDA's orphan drug designationMinneapolis Star Tribune (blog)all 21 news articles��
Blog Content
Post a Comment